Though Teva Pharmaceutical has remained confident its closely watched migraine medication fremanezumab will launch later this year, problems continue to hang over the facility responsible for producing it.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,